Today: 8 June 2026
Browse Category

NASDAQ:RCUS 13 January 2026

Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage

Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage

Arcus Biosciences shares rose 4.8% to $22.32 Tuesday after Goldman Sachs upgraded the stock to “Buy” and raised its price target. The move followed early Phase 1 data for lead drug casdatifan showing response rates of 31% alone and 46% in combination for advanced kidney cancer. Arcus plans to present at the J.P. Morgan Healthcare Conference on Wednesday. The company reported $1 billion in cash and funding into late 2028.
13 January 2026
·

Stock Market Today

  • AI Stock Selloff on Friday Sparks Buying Opportunity; Asia Markets Drop
    June 8, 2026, 2:53 PM EDT. The Nasdaq experienced its worst session in a year on Friday, with AI-focused chipmakers like Micron and Broadcom dropping sharply but rebounding by over 6.5% by Monday midday. Morgan Stanley called the selloff a "healthy reset" amid record gains since March. However, Asia's markets reacted differently: South Korea's KOSPI fell 8.29%, triggering a trading halt due to declines in Samsung and SK Hynix shares. Nvidia CEO Jensen Huang reaffirmed strong demand for AI chips, projecting $1 trillion in sales by 2027. Meanwhile, a strong May jobs report in the U.S. increased expectations for a Federal Reserve rate hike, which could pressure high-growth AI stocks. This complex backdrop highlights cautious optimism amid volatility in the AI investment trade.

Latest articles

Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

8 June 2026
Nu Holdings shares slid 3.1% to $11.60 as investors weighed CFO transition risks and rising credit costs, erasing last week’s 4.1% buyback-driven bounce; BofA downgraded the stock to Underperform with a $10 target, citing uncertainty from Lago’s exit, while Nu’s $1B buyback failed to stem a 10.7% weekly drop and 30.7% year-to-date decline, leaving shares just above their 52-week low.
Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

8 June 2026
Inno Holdings shares soared twentyfold to $20.97 after announcing a $3 million AI sales agent deal for its used mobile phone business, but investor risks remain with a recent $60 million at-the-market stock program and ongoing going-concern warnings in filings, as the project is still in early development and not yet commercially launched.
Emirates Cuts A380 Flights, Raising Concerns Over Summer Airfare

Emirates Cuts A380 Flights, Raising Concerns Over Summer Airfare

8 June 2026
Emirates slashed June A380 flights on 10 major routes as soaring fuel costs and Middle East airspace disruption forced airlines to cut capacity, prompting IATA to halve its 2026 global profit forecast to $23 billion from $41 billion, with industry-wide seat reductions and rising fares expected as carriers struggle to absorb shocks during peak travel.
Wall Street Watches Microsoft’s $37 Billion AI Bet

Wall Street Watches Microsoft’s $37 Billion AI Bet

8 June 2026
Microsoft shares fell 1.5% to $410.30 as investors weighed bullish analyst calls and NHS England’s Copilot rollout against concerns that surging AI revenue—now at a $37 billion run rate—may not outpace rising costs and margin pressure from heavy infrastructure investment.
Cerebras shares jump as Wall Street eyes AI chipmaker’s Nvidia bid

Cerebras shares jump as Wall Street eyes AI chipmaker’s Nvidia bid

8 June 2026
Cerebras shares soared about 20% to $241.44 after Wall Street analysts initiated coverage post-IPO, citing rapid demand for fast AI inference and partnerships with OpenAI and AWS; Needham set a $300 price target, while the average analyst forecast reached $295, as chip stocks broadly rebounded and the PHLX Semiconductor Index jumped over 6%.
Go toTop